Answer
Breastfeeding should be discontinued during avapritinib treatment and for 2 weeks after the final dose because a risk to newborns or infants cannot be excluded.
Sources for this answer
- AYVAKYT 300 mg film-coated tabletsBlueprint Medicines (Netherlands) B.V. · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked